Profilo
Marc Bonneville is the founder of Innate Pharma SA, which was founded in 1999.
He is currently the Director at Global Virus Network and Vice President-Medical & Scientific Affairs at Institut Mérieux SA since 2013.
Dr. Bonneville's former positions include Research Director at Centre National de la Recherche Scientifique, Director at Platine Pharma Services SAS, and Independent Director at GeNeuro SA (Switzerland) from 2015 to 2020.
Dr. Bonneville holds a doctorate degree from Massachusetts Institute of Technology.
Posizioni attive di Marc Bonneville
| Società | Posizione | Inizio |
|---|---|---|
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Provides solutions for multifactorial management of diseases | Direttore Tecnico/Scientifico/R&S | 01/01/2013 |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Marc Bonneville
| Società | Posizione | Fine |
|---|---|---|
| GENEURO SA | Direttore/Membro del Consiglio | 25/09/2020 |
Centre National de la Recherche Scientifique
Centre National de la Recherche Scientifique General GovernmentGovernment Provides scientific research services | Corporate Officer/Principal | 01/01/2013 |
Platine Pharma Services SAS
Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Provides immune-monitoring services | Direttore/Membro del Consiglio | - |
| INNATE PHARMA | Fondatore | - |
Formazione di Marc Bonneville
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Innate Pharma SA
Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
Centre National de la Recherche Scientifique
Centre National de la Recherche Scientifique General GovernmentGovernment Provides scientific research services | Government |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Provides solutions for multifactorial management of diseases | Health Technology |
Platine Pharma Services SAS
Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Provides immune-monitoring services | Health Services |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Commercial Services |
GeNeuro SA (Switzerland)
GeNeuro SA (Switzerland) BiotechnologyHealth Technology Engages in the research and development of pharmaceutical products to treat neurological diseases | Health Technology |
















